Contravisory Investment Management, Inc. Adma Biologics, Inc. Transaction History
Contravisory Investment Management, Inc.
- $442 Million
- Q4 2024
A detailed history of Contravisory Investment Management, Inc. transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Contravisory Investment Management, Inc. holds 10,811 shares of ADMA stock, worth $182,381. This represents 0.04% of its overall portfolio holdings.
Number of Shares
10,811
Previous 10,811
-0.0%
Holding current value
$182,381
Previous $216,000
14.35%
% of portfolio
0.04%
Previous 0.05%
Shares
1 transactions
Others Institutions Holding ADMA
# of Institutions
326Shares Held
190MCall Options Held
917KPut Options Held
91.6K-
Black Rock Inc. New York, NY18.6MShares$315 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.1MShares$306 Million0.01% of portfolio
-
State Street Corp Boston, MA13MShares$219 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA12.6MShares$213 Million0.05% of portfolio
-
Morgan Stanley New York, NY8.6MShares$145 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.31B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...